Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FIRSTMAPPP: Sunitinib in Malignant Progressive Pheochromocytoma and Paraganglioma
NCT01371201Phase 2Completed
- Sponsor
- Gustave Roussy
- Start
- Dec 2011
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of sunitinib in pheochromocytoma, malignant paraganglioma, sponsored by Gustave Roussy. Started Dec 2011; status: completed.
02
Drugs
sunitinib
03
Conditions
pheochromocytomamalignant paraganglioma
Beyond the preview
Go deeper on NCT01371201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01371201.